Gender differences in the presentation of subjects with restless legs syndrome

被引:20
作者
Bentley, AJ
Rosman, KD
Mitchell, D
机构
[1] Univ Witwatersrand, Wits Dial A Bed Sleep Lab, Brain Funct Res Unit, Sch Physiol, ZA-2193 Johannesburg, South Africa
[2] SleepWake Labs, Johannesburg, South Africa
关键词
restless legs syndrome; sleep disorder symptoms; family history; gender bias;
D O I
10.1016/j.sleep.2005.03.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: To better understand the origin of the disproportionate number of women in previous treatment studies of patients with restless legs syndrome (RLS). Patients and methods: We conducted a survey in a self-selected group of patients who responded to print and radio recruiting advertisements regarding a clinical trial for RLS. Subjects completed a questionnaire which solicited information on presenting features of RLS, sleep-related symptoms, co-morbidities and family history. Results: A total of 158 (63% female) subjects with a mean age of 49 (+/- 16) years fulfilled the criteria for putative diagnosis of RLS and participated in the study. There was no gender bias as far as duration of RLS, incidence of family history, number of affected days per week, or severity of daytime sleepiness was concerned. There was a subtle gender bias in sleep-related symptoms (involuntary movements when awake, sleep onset difficulties and frequent wakings at night) where a disproportionately high number of women subjects presented with all three symptoms. For any one symptom, or any pair of symptoms, there were no gender differences. Women also were more likely to present with co-existent hypothyroidism. Both male and female subjects were more likely to recall female relatives affected with RLS. Conclusions: Gender differences associated with symptom load, co-morbidities of RLS and possible patterns of inheritance may contribute to increased numbers of women presenting for treatment of RLS. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 25 条
  • [1] Evaluating the quality of life of patients with restless legs syndrome
    Abetz, L
    Allen, R
    Follet, A
    Washburn, T
    Earley, C
    Kirsch, J
    Knight, H
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (06) : 925 - 935
  • [2] Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health
    Allen, RP
    Picchietti, D
    Hening, WA
    Trenkwalder, C
    Walters, AS
    Montplaisi, J
    [J]. SLEEP MEDICINE, 2003, 4 (02) : 101 - 119
  • [3] Restless legs syndrome in 218 patients: associated disorders
    Banno, Katsuhisa
    Delaive, Kenneth
    Walld, Randy
    Kryger, Meir H.
    [J]. SLEEP MEDICINE, 2000, 1 (03) : 221 - 229
  • [4] Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: Results from an open-label 6-month clinical trial
    Benes, H
    Heinrich, CR
    Ueberall, MA
    Kohnen, R
    [J]. SLEEP, 2004, 27 (04): : 674 - 682
  • [5] Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study
    Hening, W
    Walters, AS
    Allen, RP
    Montplaisir, J
    Myers, A
    Ferini-Strambi, L
    [J]. SLEEP MEDICINE, 2004, 5 (03) : 237 - 246
  • [6] Hening W, 1999, SLEEP, V22, P970
  • [7] A NEW METHOD FOR MEASURING DAYTIME SLEEPINESS - THE EPWORTH SLEEPINESS SCALE
    JOHNS, MW
    [J]. SLEEP, 1991, 14 (06) : 540 - 545
  • [8] LAVIGNE GJ, 1994, SLEEP, V17, P739
  • [9] Lazzarini A, 1999, MOVEMENT DISORD, V14, P111, DOI 10.1002/1531-8257(199901)14:1<111::AID-MDS1018>3.0.CO
  • [10] 2-9